Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Refractory Status Epilepticus Treatment (RESET): Quality and Efficacy of Coma Induction

NCT04333082 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.

NCT NCT04333082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04333082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Refractory Status Epilepticus Treatment (RESET): Quality and Efficacy of Coma Induction
Lead sponsor
University Hospital, Basel, Switzerland
Phase
Observational
Overall status
Completed
Start date
April 22, 2020
Completion date
August 3, 2022
Enrollment
147 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory status epilepticus, status epilepticus